Low grade serous ovarian carcinoma presenting with monoparesis due to deep vein thrombosis: a case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254310Keywords:
Low-grade serous ovarian carcinoma, Deep vein thrombosis, Monoparesis, Venous thromboembolism, Atypical presentationAbstract
Low-grade serous ovarian carcinoma (LGSOC) is a rare and indolent form of ovarian cancer. While it commonly presents with abdominal symptoms, unusual manifestations such as neurological deficits are less frequent. This case report explores an atypical presentation of LGSOC associated with deep vein thrombosis (DVT) leading to monoparesis. A 45-year-old multiparous female, regular menstrual cycles presented with sudden onset of swelling and pain in her left lower limb. Physical examination revealed tender and swollen left lower limb with Homan’s sign, with imaging confirming DVT in multiple lower limb veins. Further investigation, including pelvic imaging, revealed an ovarian mass. DVT was managed conservatively and patient had total abdominal hysterectomy with bilateral salpingo oophorectomy. Biopsy revealed LGSOC with external iliac vein thrombosis. The tumor was initially asymptomatic, and the neurological symptoms were attributed to paraneoplastic syndrome secondary to the DVT rather than direct tumor invasion. This case highlights an atypical presentation of LGSOC where DVT complicated by monoparesis was the primary symptom. It underscores the importance of considering underlying malignancies in patients with unexplained neurological symptoms and venous thromboembolism (VTE). Early recognition and comprehensive evaluation are crucial for appropriate diagnosis and management. LGSOC can present with unusual neurological symptoms, particularly when complicated by DVT. Clinicians should be vigilant for potential malignancies in patients with unexplained monoparesis and thromboembolic events to ensure timely and effective treatment.
References
Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol. 2016;34(24):2888-98.
Köbel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, et al. Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, Vancouver BC. Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol. 2010;29(3):203-11.
WHO Classification of Tumours Editorial Board. WHO classification of tumours of female genital tumours. 5th ed. Vol. 4. Lyon: International Agency for Research on Cancer; 2020. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Who-Classification-Of-Tumours/Female-Genital-Tumours-2020. Accessed on 20 November 2025.
Matsuo K, Machida H, Matsuzaki S, Grubbs BH, Klar M, Roman LD, et al. Evolving population-based statistics for rare epithelial ovarian cancers. Gynecol Oncol. 2020;157(1):3-11.
Lee AY, Levine MN, Butler G, Webb C, Costantini L, Gu C, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol. 2006;24(9):1404-8.
Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465-73.
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110(10):2339-46.
Gao S, Escalante C. Venous thromboembolism and malignancy. Expert Rev Anticancer Ther. 2004;4(2):303-20.
Samuel GO, Yaa AA, Nikola S. Venous thromboembolismin women with ovarian cancer undergoing neoadjuvant chemo-therapy prior to cytoreductive surgery: A retrospective study. Acta Obstet Gynecol Scand. 2021;100:2091-6.
Metcalf RL, Fry DJ, Swindell R, McGurk A, Clamp AR, Jayson GC, et al. Thrombosis in ovarian cancer: a case control study. Br J Cancer. 2014;110(5):1118-24.